JACQUELINE PAPADOPOULOS, PHARMD, RPH
Ambulatory Care Pharmacist in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JACQUELINE PAPADOPOULOS, PHARMD, RPH filed 315 Medicare Part D claims in 2023 as a Ambulatory Care Pharmacist in BOSTON, Massachusetts, prescribing 39% generic.
- 315
- Part D claims, 2023
- 39%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JACQUELINE PAPADOPOULOS, PHARMD, RPH's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
315 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about JACQUELINE PAPADOPOULOS, PHARMD, RPH?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Ambulatory Care Pharmacist compares to other specialties among Massachusetts providers
Ambulatory Care Pharmacist share within Massachusetts
Ambulatory Care Pharmacist is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Ambulatory Care Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Ambulatory Care Pharmacist ABMS/AOA estimate
Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Ambulatory Care Pharmacist US NPIs
Specialty board-certified rate — Ambulatory Care Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JACQUELINE PAPADOPOULOS, PHARMD, RPH is a Ambulatory Care Pharmacist provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD, RPH. NPI: 1225549181. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
JACQUELINE PAPADOPOULOS, PHARMD, RPH appears in the CMS NPPES registry as a Ambulatory Care Pharmacist provider holding PHARMD, RPH credentials at 75 FRANCIS ST, BOSTON, MA, 02115, with a listed phone of (617) 732-5500. NPI 1225549181 was issued on 10/18/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PAPADOPOULOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 315 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $184K in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,473 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225549181 |
|---|---|
| Specialty | Ambulatory Care Pharmacist |
| Credentials | PHARMD, RPH |
| Gender | Female |
| NPI Issued | 10/18/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JACQUELINE PAPADOPOULOS, PHARMD, RPH's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to JACQUELINE PAPADOPOULOS, PHARMD, RPH. To verify JACQUELINE PAPADOPOULOS, PHARMD, RPH's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
61% brand-name claims vs 39% generic, on 315 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 664
- Total Day Supply
- 19,739
- Brand vs Generic
- 61% brand / 39% generic
- Brand Drug Cost
- $180K
- Generic Drug Cost
- $2K
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Trulicity Dulaglutide | 50 |
| Ozempic Semaglutide | 34 |
| Metformin Hcl Er Metformin Hcl | 24 |
| Jardiance Empagliflozin | 16 |
| Amlodipine Besylate | 14 |
| Metformin Hcl | 14 |
| Novolog Flexpen Insulin Aspart | 14 |
| Januvia Sitagliptin Phosphate | 11 |
| Lisinopril | 11 |
| Basaglar Kwikpen U-100 "Insulin Glargine | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Pharmacist Overview
How JACQUELINE PAPADOPOULOS, PHARMD, RPH fits within the Ambulatory Care Pharmacist landscape nationally.
JACQUELINE PAPADOPOULOS, PHARMD, RPH's 315 claims are below the specialty average of 492.
Nearby Ambulatory Care Pharmacist Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as PAPADOPOULOS.
Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is JACQUELINE PAPADOPOULOS, PHARMD, RPH's specialty? ▼
How much does JACQUELINE PAPADOPOULOS, PHARMD, RPH prescribe under Medicare Part D? ▼
Where is JACQUELINE PAPADOPOULOS, PHARMD, RPH located? ▼
What is JACQUELINE PAPADOPOULOS, PHARMD, RPH's NPI number? ▼
Does JACQUELINE PAPADOPOULOS, PHARMD, RPH prescribe more brand-name or generic drugs? ▼
How many Ambulatory Care Pharmacist providers are there in the US? ▼
What drugs does JACQUELINE PAPADOPOULOS, PHARMD, RPH prescribe most often? ▼
Does JACQUELINE PAPADOPOULOS, PHARMD, RPH accept Medicare? ▼
How can I verify JACQUELINE PAPADOPOULOS, PHARMD, RPH's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology